Commit Biologics Breakthrough: Enhancing Immunotherapy with Novel Complement Engager Platform Commit Biologics announces promising results from its Complement Engager platform in NHPs, demonstrating fast, effective immune cell depletion with a safe profile.

Commit Biologics Breakthrough: Enhancing Immunotherapy with Novel Complement Engager Platform #Denmark #Aarhus #Commit_Biologics #Complement_Engager #BiCE™